JSP 545
Pill imprint JSP 545 has been identified as Digoxin 250 mcg (0.25 mg).
Digoxin is used in the treatment of heart failure; atrial fibrillation and belongs to the drug classes group V antiarrhythmics, inotropic agents. Risk cannot be ruled out during pregnancy.
Digoxin 250 mcg (0.25 mg) is not subject to the Controlled Substances Act.
See also related documents.
Digoxin Images
- Imprint:
-
JSP 545
- Strength:
- 250 mcg (0.25 mg)
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Group V antiarrhythmics
Inotropic agents - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Lannett Company, Inc.
- National Drug Code (NDC):
- 00527-1325
| NDC Code | Manufacturer / Repackager |
|---|---|
| 62584-0990 | Amerisource Health Services |
| 66336-0607 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Digoxin resources
- Digoxin
- Digoxin (Wolters Kluwer)
- Digoxin Capsules (Wolters Kluwer)
- Digoxin Elixir (Wolters Kluwer)
- digoxin (Cerner Multum)
- Digitaline Nativelle (Micromedex) - Includes Dosage Information
- digoxin (Micromedex) - Includes Dosage Information
- digoxin Intravenous (Micromedex) - Includes Dosage Information
- Digoxin (AHFS DI)
- Digoxin Injection (FDA)
- Digoxin Oral Solution (FDA)
- Digoxin Tablets (FDA)
- Lanoxin Injection Pediatric (FDA)
- Lanoxin Tablets (FDA)
- Digoxin (Wolters Kluwer)
- Digitalis (Wolters Kluwer)
Search Again
